| Net loss | |
| Depreciation and amortization of property and equipment | 517K |
| Loss on disposal of equipment | 1K |
| Non-cash impairment charges | |
| Non-cash restructuring expenses, net of reversals | |
| Non-cash interest expense | 395K |
| Non-cash forgiveness of loans to officers | |
| Stock-based compensation | 5.27M |
| Non-cash warrant expense | |
| Other non-cash expenses | |
| Related party accounts receivable | -66.99M |
| Prepaid and other assets | -922K |
| Accounts payable | -1.33M |
| Accrued liabilities | 9.12M |
| Related party payables and accrued liabilities | |
| Deferred revenue | 5.28M |
| Net cash used in operating activities | |
| Purchases of investments | -79.97M |
| Proceeds from sales and maturities of investments | 70.57M |
| Proceeds from sales of auction rate securities | |
| Purchases of property and equipment | -742K |
| Proceeds from sales of property and equipment | 33K |
| (Increase) decrease in restricted cash | |
| Issuance of related party notes receivable | |
| Proceeds from repayments of notes receivable | |
| Net cash provided by (used in) investing activities | |
| Proceeds from initial public offering, sale of common stock to related party, and public offerings, net of issuance costs | |
| Proceeds from draw down of committed equity financing and at-the-market facility, net of issuance costs | |
| Proceeds from other issuances of common stock and warrants, net of issuance costs | |
| Proceeds from issuance of preferred stock, net of issuance costs | |
| Repurchase of common stock | |
| Proceeds from loan with UBS | |
| Repayment of loan with UBS | |
| Proceeds from equipment financing lines | |
| Repayment of equipment financing lines | |
| Net cash provided by (used in) financing activities | |
| Net increase (decrease) in cash and cash equivalents | -34.78M |
| Cash and cash equivalents, beginning of period | 65.08M |
| Cash and cash equivalents, end of period | 30.3M |